A novel peptide RIFV suppresses human adipocyte differentiation through the inhibition of C/EBP-β expression

BACKGROUND: Obesity is a global epidemic disease that increases the risk of metabolic syndrome. However, therapeutic drugs for obesity are still scarce. In recent years, peptides have been identified as new biological regulators. RIFV (R-I-F-V-P-I-K-G-R-P-A-P), a novel active peptide from our peptid...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Nutr Metab (Lond)
Egile Nagusiak: Zhang, Wen, Shen, Dan, Li, Yun, Zhong, Hong, Wang, Xing, Cui, Xian-wei, Shi, Chun-Mei, Ji, Chen-Bo, Guo, Xi-Rong, Chen, Ling
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2019
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6929371/
https://ncbi.nlm.nih.gov/pubmed/31889968
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12986-019-0414-z
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak